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OBJECTIVE The objective was to investigate mechanisms of vasovagal syncope by identifying laboratory
techniques that characterize cardiovascular profiles in patients with vasovagal syncope.
BACKGROUND The triggering mechanisms of vasovagal syncope are complex. The patient population is likely
heterogeneous. We hypothesized that distinct hemodynamic profiles are definable with
provocative maneuvers.
METHODS Three groups of subjects were matched for age and gender: 16 patients with a history of
syncope and an inducible vasovagal response during passive tilt table testing (70°, 45 min,
group I), 16 with a history of syncope, negative passive tilt table testing but positive
isoproterenol tilt table testing (0.05 mg/kg per min, 70°, 10 min, group II), and 16 control
subjects. Beat-to-beat hemodynamic functions were determined noninvasively by photo-
plethysmography and impedance cardiography.
RESULTS At baseline, hemodynamic functions were not different among the three groups (supine). In
response to tilt before any symptoms developed, total peripheral resistance decreased 9% 6
14% in group I from baseline supine to tilt position but increased 27% 6 18% in group II and
28% 6 17% in controls (p , 0.001). Responses to isoproterenol were not significantly
different between group II and controls in supine position. In response to tilt during
isoproterenol infusion before any symptoms developed, total peripheral resistance decreased
24% 6 20% in group II and increased 20% 6 48% in controls (p 5 0.002).
CONCLUSIONS Group I patients may have impaired ability to increase vascular resistance during orthostatic
stress. The inability to overcome isoproterenol-induced vasodilatation during tilt is important
in triggering a vasovagal response in group II patients. These data suggest that the population
with vasovagal response is heterogeneous. Distinct hemodynamic profiles in response to
various provocative maneuvers are definable with noninvasive, continuous monitoring
techniques. (J Am Coll Cardiol 2000;35:1470–7) © 2000 by the American College of
Cardiology
The pathophysiology of the vasovagal state is not com-
pletely understood. The most likely explanation of how
vasovagal syncope is triggered is the Bezold-Jarisch reflex
(1–5). The reflex loop includes venous pooling (preload
reduction), activation of cardiac mechanoreceptors, trans-
mission via C fibers (i.e., vagal afferents), central integration
(nucleus tractus solitarius) and efferent discharge culminat-
ing in vasodilation or bradycardia (or both). This, in turn,
leads to the hypotension and loss of consciousness associ-
ated with vasovagal syncope. Triggering of vasovagal syn-
cope, however, most likely involves mechanisms other than
those described by the Bezold-Jarisch reflex. Although
cardiac afferents may have a role in this response, they
clearly are not obligatory because typical vasodepressor
responses may occur after heart transplantation with well-
documented sympathetic inhibition in the absence of any
significant bradycardia (6–8). Several peripheral (9,10) and
central (11–16) neurotransmitters and vasoactive peptides
have been suggested to have a role in modulating vasovagal
syncope. Although decreases in end-systolic and end-
diastolic areas have been observed echocardiographically at
the end of tilt table testing in patients with vasovagal
syncope (17–19), we recently reported that a significant
reduction of end-diastolic volume, estimated by impedance
cardiography, was not observed immediately before
isoproterenol-induced vasovagal syncope (20).
Divergent observations in plasma concentrations of nor-
epinephrine (21–24) and heart rate (HR) variability (19,25–
28) have been reported by various investigators. Consistent
observations on humoral and autonomic abnormalities have
been difficult to achieve, perhaps because of: 1) the transient
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and paroxysmal nature of the syndrome, 2) the inability to
continuously monitor hemodynamic functions preceding
and during a vasovagal response, and 3) multiple triggering
mechanisms in a heterogeneous patient population.
A blunted increase in muscle neural sympathetic dis-
charge was reported recently in habitual fainters and a
markedly enhanced sympathetic discharge in occasional
fainters (29), suggesting that the clinical history and pre-
sentation may be correlated with various triggering mecha-
nisms of vasovagal syncope. Pathogenetic triggering
mechanisms of vasovagal syncope are likely protean. Com-
binations and permutations of these mechanisms reflect the
complexity and heterogeneity of the patient population.
Although precise identification of the triggering mecha-
nisms of vasovagal syncope is key to effective therapy, our
ability to differentiate the various mechanisms and subsets of
patients is limited.
In this study, we prospectively assessed beat-to-beat,
continuous hemodynamic changes in three groups of sub-
jects with distinct responses to tilt table testing: 1) patients
with a history of syncope and a vasovagal response during
passive tilt table testing; 2) patients with a history of
syncope, no vasovagal response to passive tilt table testing,
but a positive response during isoproterenol tilt table test-
ing; and 3) control subjects without a vasovagal reaction.
We hypothesized that the patient population prone to
vasovagal syncope is heterogeneous. Different hemodynamic
profiles can be defined with various provocative maneuvers.
The overall goal of this study was to investigate the
mechanisms that trigger vasovagal syncope by identifying
laboratory techniques that can be used to characterize the
cardiovascular profiles of patients with vasovagal syncope.
METHODS
Patient selection. The study group included 16 patients
with inducible vasovagal response during passive tilt table
testing (group I) and 16 patients without an inducible
vasovagal response to passive tilt table testing but a positive
response to isoproterenol tilt table testing (group II). Also
included was an age- and gender-matched control group.
Patients were selected from a consecutive group of patients
who had tilt table testing because of a history of recurrent
syncope without any known cardiovascular disease. Control
subjects did not have any known cardiovascular disease or
history of near syncope, syncope or orthostatic intolerance.
The study protocol was approved by the Institutional
Review Board of Mayo Foundation. Informed consent was
obtained verbally from all patients and in writing from all
control subjects.
Tilt table and isoproterenol testing protocol. Each pa-
tient was monitored in the supine position (baseline supine)
for 10 min and then at a 70° angle (baseline tilt) for up to
45 min. For patients in group I, the test was terminated
when a vasovagal response was induced. For patients in
group II, one-stage isoproterenol tilt table testing was
performed (30). With the patient supine, a constant isopro-
terenol infusion was initiated at 0.05 mg/kg per min. When
HR reached a steady state with isoproterenol (isosupine),
the subject was monitored for another 3 min in the supine
position before repeated tilting (isotilt); the test was termi-
nated when a vasovagal response was induced. In the control
group, each subject completed the sequential baseline tilt
and the isotilt. The duration of the isotilt was 10 min.
Hemodynamic monitoring. A volume clamp photo-
plethysmographic blood pressure (BP) probe (Finapres
monitor, Ohmeda, Englewood, Colorado) was attached to
the left index finger. Thoracic impedance (Z) was measured
by four pairs of electrodes attached to the upper and lower
thorax and connected to an NCCOM 3-R7 cardiodynamic
monitor (Biomed Medical Manufacturing, Ltd, Irvine,
California). Fluctuations of Z (correlated with pulsatile
aortic flow) were measured by injecting high-frequency and
low-intensity alternating current through these electrodes.
Stroke volume (SV) was estimated by the following equa-
tion:
SV 5 V 3 T 3
~dZ/dt!
Z0
in which V is the volume of electrical participating tissue,
calculated from the patient’s gender, height and adjusted
weight; T is ventricular ejection time; Z0 is mean thoracic
impedance; and dZ/dt is maximal rate of change of thoracic
impedance.
The theoretical basis and validation of estimating SV
from thoracic impedance measurements were established by
Kubicek et al. (31) and redefined by Bernstein (32,33).
Systolic (SBP), diastolic (DBP) and mean (MBP) blood
pressure, HR and SV were measured, and beat-to-beat
cardiac output (CO) and total peripheral resistance (TPR)
were calculated online and displayed continuously during
the isoproterenol tilt table test. The reliability and validation
of impedance cardiography have been reviewed critically
(34–36).
Data acquisition. The data from hemodynamic monitor-
ing were entered into an IBM personal computer with real-
time data acquisition software developed under a program
project. The electrocardiogram signal was detected to an
Abbreviations and Acronyms
BP 5 blood pressure
CO 5 cardiac output
DBP 5 diastolic blood pressure
HR 5 heart rate
MBP 5 mean blood pressure
SBP 5 systolic blood pressure
SV 5 stroke volume
TPR 5 total peripheral resistance
Z 5 thoracic impedance
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accuracy of 2 ms. Instantaneous HR was calculated from the
RR interval. The analog output of the finger probe was
sampled at 100 Hz. Maximal and minimal points between
QRS complexes were converted by the computer (sample
rate, 500 Hz) for continuous display and were stored for
later analysis.
Data presentation. During the baseline supine and isosu-
pine stages of the testing protocol, a data point was obtained
during each stage while the subject was in a steady-state
condition. Each data point was calculated from an average
of 15 consecutive artifact-free samples, acquired at a fre-
quency of 1 Hz, so that each point represented a 10- to 20-s
epoch. During baseline tilt and isotilt stages, the data point
was obtained between 30 s and 60 s after the subject was in
the final tilt position. For group II, this data point was
obtained before the onset of any symptoms.
Statistical analysis. Percent changes from baseline for each
mechanical or pharmacologic intervention were summarized
as mean 6 standard deviation. A two-sample t test was used
to test differences between groups I and II if the data were
normally distributed. If not, the Wilcoxon rank sum test was
used. Analysis of variance was used to test differences among
groups I and II and the control group if the data were
normally distributed. If not, the Kruskal-Wallis test was
used. Duncan’s multiple range procedure was used to
identify differences among the three groups. All p values
were two-sided, and a type I error level of 0.05 was used.
RESULTS
Patient and control subject characteristics. The clinical
characteristics of the 16 patients in group I and group II are
summarized in Table 1. Of the 16 patients in each group,
eight were women and eight were men. The mean age was
38 6 15 years for group I and 37 6 13 years for group II
(p 5 0.6). All patients had a history of recurrent syncope.
None had significant cardiovascular disease, and none was
taking a vasoactive or diuretic agent at the time of the tilt
table test. The mean age for the control group was 39 6 14
years. The hemodynamic variables were grouped into car-
diomotor (HR, SV and CO; Table 2) and vasomotor (SBP,
DBP, MBP and TPR; Table 3) functions. Sequential
changes during baseline tilt, isosupine and isotilt were
compared with baseline supine values.
Table 1. Patient Characteristics
Characteristic
Control
Group Group I* Group II†
No. of subjects 16 16 16
Gender (F/M) 8/8 8/8 8/8
Mean age 6 SD, yr 39 6 14 38 6 15 37 6 13
No. of syncope episodes
(previous year)
— 3 6 3 (range, 1–10) 3 6 4 (range, 1–12)
Ejection fraction, % — 61 6 6 (n 5 11) 59 6 5 (n 5 10)
Time to syncope, min — 19.3 6 10.5 4.0 6 2.8
*Group I, patients with vasovagal response to passive tilt table testing; †Group II, patients without vasovagal response to passive
tilt table testing but a positive response to isoproterenol tilt table testing.
Table 2. Cardiomotor Function in Response to Tilt Table Testing and Isoproterenol*
Baseline
Supine Baseline Tilt at 70° Isosupine† Isotilt‡
HR, beats/min
Control group 63 6 9 70 6 10 107 6 21 113 6 23
Group I 67 6 18 84 6 26 — —
Group II 69 6 10 78 6 12 103 6 20 113 6 17
SV, mL
Control group 105 6 29 84 6 23 115 6 50 116 6 42
Group I 88 6 27 82 6 30 — —
Group II 95 6 15 76 6 14 103 6 26 118 6 21
CO, L/min
Control group 7 6 2 6 6 2 12 6 5 13 6 6
Group I 6 6 2 6 6 1 — —
Group II 6 6 1 6 6 2 11 6 3 13 6 3
*For definition of groups, see Table 1; †Isosupine, isoproterenol infusion with the subject supine; ‡Isotilt, isoproterenol infusion
with the subject tilted 70°.
CO 5 cardiac output; HR 5 heart rate; SV 5 stroke volume.
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Baseline supine hemodynamics. The hemodynamic pa-
rameters are summarized in Tables 2 and 3. In the baseline
supine position, cardiomotor findings were similar for all
three groups (HR, p 5 0.3; SV, p 5 0.2; CO, p 5 0.1), as
were vasomotor functions (SBP, p 5 0.7; DBP, p 5 0.4;
MBP, p 5 0.5; TPR, p 5 0.5).
Response to passive tilt. In response to tilting in group I
(Fig. 1A), HR increased by 25% 6 26%, SV decreased by
5% 6 25% and calculated CO increased by 10% 6 18%,
and, in group II, HR increased by 12% 6 15% and SV and
CO decreased by 20% 6 12% and 11% 6 7%, respectively.
In response to tilting in the control group, HR increased by
12% 6 15% and SV and CO decreased by 19% 6 11% and
14% 6 11%, respectively. The change in stroke volume in
group I was significantly different (p 5 0.04) from that in
the other two groups, as was the change in CO (p , 0.001).
Changes in vasomotor functions in response to passive tilt
are shown in Figure 1B. Systolic blood pressure, DBP and
MBP increased in the control group and in group II but
showed minimal change in group I. Total peripheral resis-
tance decreased 9% 6 14% in group I and increased 27% 6
18% and 28% 6 17% in group II and the control group,
respectively. The relative change in TPR in group I was
significantly different from that of the other two groups
(p , 0.001).
Response to isoproterenol in the supine position. With
subjects supine, cardiomotor function increased in response
to isoproterenol in group II and in the control group (Table
2). The percent changes from baseline are displayed in
Figure 2A. In group II, this increase was 49% 6 16%, 9% 6
22% and 62% 6 34% for HR, SV and CO, respectively. In
the control group, HR, SV and CO increased 67% 6 25%,
10% 6 28% and 78% 6 51%, respectively. These values
were not significantly different between the two groups
(HR, p 5 0.05; SV, p 5 0.9; CO, p 5 0.5).
The effects of isoproterenol on the vasomotor functions in
the supine position and in comparison with baseline values
in group II and in the control group are shown in Table 3.
The percent changes from baseline are shown in Figure 3A.
Blood pressure was stable in both groups during isoproter-
enol infusion, but TPR decreased 38% 6 17% in group II and
40% 6 23% in the control group. The differences between the
two groups were not significant (p 5 0.8, Fig. 3A).
Response to tilt during isoproterenol infusion. Changes
in cardiomotor functions immediately after tilting up and
before the onset of vasovagal symptoms in group II are
summarized in Table 2. The percent changes are shown in
Figure 2B. From isosupine to isotilt, HR, SV and CO
increased 13% 6 15%, 19% 6 30% and 31% 6 34%,
respectively, in group II and 7% 6 17%, 5% 6 30% and
9% 6 36% in the control group. The differences between
the two groups were not significant (HR, p 5 0.5; SV, p 5
0.3; CO, p 5 0.1).
The greatest difference between group II and the control
group was in vasomotor functions. In the control group, BP
increased slightly from the isosupine to the isotilt position
(Table 3), and TPR increased 20% 6 48% (Fig. 3B). In
comparison, BP decreased slightly in group II from the
isosupine to the isotilt position (Table 3). Total peripheral
resistance decreased 24% 6 20% immediately after tilting
during isoproterenol infusion. The difference between the
two groups was significant (p 5 0.002).
Table 3. Vasomotor Function in Response to Tilt Table Testing and Isoproterenol*
Baseline
Supine
Baseline Tilt
at 70° Isosupine† Isotilt‡
SBP, mm Hg
Control group 139 6 16 147 6 21§ 146 6 36 64 6 22§
Group I 138 6 24 135 6 29 — —
Group II 144 6 27 160 6 31 152 6 34 139 6 33
DBP, mm Hg
Control group 83 6 15 94 6 21 74 6 23 87 6 19
Group I 87 6 23 89 6 25 — —
Group II 91 6 13 103 6 21 79 6 17 76 6 21
MBP, mm Hg
Control group 101 6 12 111 6 20 97 6 26 112 6 17§
Group I 104 6 22 104 6 25 — —
Group II 108 6 16 122 6 23 103 6 21 97 6 23
TPR, dyneszszcm3
Control group 1,296 6 397 1,651 6 492 741 6 368 819 6 321§
Group I 1,609 6 736 1,427 6 588 — —
Group II 1,370 6 282 1,754 6 474 840 6 293 599 6 156
*For definition of groups, see Table 1; †Isosupine, isoproterenol infusion with the subject supine; ‡Isotilt, isoproterenol infusion
with the subject tilted 70°; §p , 0.05.
DBP 5 diastolic blood pressure; MBP 5 mean blood pressure; SBP 5 systolic blood pressure; TPR 5 total peripheral
resistance.
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DISCUSSION
Main findings. Three main observations were made: 1) at
baseline, the hemodynamic variables were indistinguishable
among group I, group II and the control group; 2) before
any symptoms developed (BP remained relatively stable),
TPR was significantly lower in group I than in group II and
the control group; and 3) although cardiomotor and vaso-
motor responses were similar in group II and the control
group in the supine position during isoproterenol infusion,
vasomotor decompensation was apparent immediately after
tilting up in group II before any symptoms developed.
These observations suggest that, in group I, the activation
of vascular resistance during orthostatic challenge may be
impaired. In group II the inability to overcome
isoproterenol-induced vasodilatation during tilting is an
important factor preceding a vasovagal response. These data
support the idea that the population of patients with
vasovagal syncope is heterogeneous. Distinct hemodynamic
profiles in response to various provocative maneuvers po-
tentially can be defined by noninvasive, continuous moni-
toring techniques.
Heterogeneous population. The pathophysiologic, or the
exaggerated physiologic, response of vasovagal syncope has
been thoroughly investigated in the last 40 years (3–
5,9,12,17,19,24,27,28,37–50). The mechanisms underlying
the “triggering” component of the vasovagal response are
still elusive. Considerable effort has been made to assess
baroreceptor regulation in patients prone to vasovagal syn-
cope. Augmented cardiopulmonary receptor sensitivity has
been reported; for example, Sneddon and colleagues (47)
Figure 1. Percent of change of cardiomotor and vasomotor re-
sponse to tilt. (A) Percentage change of heart rate, stroke volume
and cardiac output from baseline supine to tilt position (70°) in the
three groups of subjects: controls, tilt-positive patients and
isoproterenol-positive patients. (B) Percentage change in systolic,
diastolic and mean blood pressure (BP) and total peripheral
resistance from supine to tilt position. *p , 0.05; ***p , 0.001.
Figure 2. Cardiomotor function and response to isoproterenol
between control subjects and isoproterenol-positive patients. (A)
Percentage change in heart rate, stroke volume and cardiac output
during isoproterenol infusion (0.05 mg/kg per min) in the supine
position compared with baseline supine position. (B) Percentage
change in heart rate, stroke volume and cardiac output during
isoproterenol infusion from supine to tilt position.
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observed exaggerated forearm vasoconstriction during the
application of subhypotensive lower body negative pressure
in patients with vasovagal syncope. In this study, forearm
vascular resistance was compared in 17 patients with and 17
patients without a positive response to tilt table testing. A
normal control group was not included. In contrast, changes
in forearm venous volume were indistinguishable between
patients with vasovagal syncope and normal controls during
similar testing procedures by Thomson and colleagues (50),
whereas a paradoxical forearm vasodilatation and a reduced
splenic venous volume response were observed in the patient
group during exercise. In this study, TPR was estimated
from impedance cardiography, reflecting a systemic and a
“net” rather than a regional response. Patient heterogeneity
and multiplicity of mechanisms are potential contributors to
these different observations. It is important to recognize that
the assessment of cardiopulmonary baroreceptor function
was made indirectly by inducing preload reduction and
measuring forearm resistance. Difficulties remain in clearly
distinguishing between a primary cardiopulmonary barore-
ceptor dysregulation and abnormalities in the afferent or
efferent organs or a central mechanism.
Power spectral analysis of RR variability has allowed the
balance between parasympathetic and sympathetic activities
to be assessed (19,25–28,51,52). An increase (19,28), a
decrease (25,26) and no change (27) have been observed in
HR in patients with vasovagal syncope. Furlan et al. (28)
recently reported different patterns of autonomic changes
preceding a vasovagal event. One group of patients had
evidence of progressive sympathetic activation and another
group had sympathetic inhibition, as estimated by HR
variability. By microneurographic techniques, Mosqueda-
Garcia and colleagues (29) also reported a blunted muscular
neural sympathetic discharge preceding a vasovagal response
in habitual fainters and marked enhancement in the neu-
rosympathetic discharge in occasional fainters. Although
these observations clearly support the idea that different
groups of patients have different autonomic patterns imme-
diately before a vasovagal response, a cause-and-effect rela-
tionship cannot be established.
Our data support the impression that normal subjects and
patients with vasovagal syncope have subtle differences in
vasomotor function. Furthermore, differences also exist
among those with vasovagal syncope. These subtle differ-
ences can be detected by orthostatic and pharmacologic
challenges in conjunction with beat-to-beat changes in
cardiovascular variables. This observation is important be-
cause these differences may represent the most “proximal”
organ abnormality, within the neurocardiogenic reflex, that
would be the true “trigger” of this reflex arc.
In our study design, the time segment between 30 and
60 s after a subject was tilted up was selected for analysis a
priori. During the intermediate phase after tilting, any
short-term adjustments are mediated primarily by the car-
diovascular reflexes. Humoral contributions to maintain and
reinforce reflexes usually do not occur until prolonged
orthostatic stress persists (53). During this time segment, all
subjects were asymptomatic. Hemodynamic responses likely
reflect baseline cardiovascular regulation and precede the
tilt-induced vasovagal response subsequently occurring in
the patient population.
Figure 3. Vasomotor function in response to isoproterenol. (A)
Percentage change in systolic, diastolic and mean blood pressure
(BP) and total peripheral resistance during isoproterenol infusion
in supine position compared with baseline supine position. (B)
Percentage change in systolic, diastolic and mean blood pressure
and total peripheral resistance during isoproterenol infusion from
supine to tilt position. **p , 0.01; ***p , 0.001.
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Abnormal vasomotor response and clinical implications.
In patients with a history of vasovagal syncope and an
inducible vasovagal response during passive tilt (group I),
TPR is significantly lower, whereas SV and CO are higher
than in control subjects and those with a vasovagal response
induced by isoproterenol (group II) (Figs. 1 and 2). We
believe these data reflect a subtle impairment of the primary
vasoconstrictive mechanism rather than a reflexogenic
mechanism because these changes were obtained immedi-
ately after tilting and before any vasovagal symptoms devel-
oped (54). It remains difficult to differentiate a primary
increase in cardiomotor function from a primary decrease in
vasomotor function. In the absence of any evidence of
vasoconstriction, our data are more consistent with the
hypothesis that vasomotor impairment is the primary mech-
anism. It is also essential to point out that these subtle
abnormalities could not have been detected without the
ability to analyze beat-to-beat information. Clinically, no
differences could be detected with HR or BP.
The differences between the control group and group II
are distinguishable only during isoproterenol infusion. The
hemodynamic responses to baseline tilt were indistinguish-
able between the two groups. A failure to overcome the
isoproterenol (beta2 receptor activation) mediated vasodila-
tation appears to be the key component of the initiating
mechanism. These observations are consistent with those of
our previous report (55).
The ability to differentiate triggering mechanisms of
vasovagal response is important. Mosqueda-Garcia and
colleagues (29) recently reported that differences in muscle
neural sympathetic discharges could be correlated with a
patient’s history of frequent versus occasional fainting.
Microneurography directly monitors neural transmission
but is invasive and is still an investigational tool. Furlan and
colleagues (28) reported distinctive patterns of HR variabil-
ity preceding the vasovagal response in first-time fainters.
Heart rate variability analysis, although noninvasive, re-
quires off-line analysis and careful interpretation. Our study
reports for the first time that patient populations can be
differentiated by clinically approved testing modalities on
the basis of potential triggering mechanisms. If a
mechanism-based therapy can be proved useful, the poten-
tial clinical applications of a mechanism-based testing pro-
tocol will be enormous.
Study limitations. The precision of hemodynamic values,
the basis of our study, is limited by the impedance cardiog-
raphy technique (34–36). Although our data suggest that
the peripheral vasculature could be the initiating component
of the vasovagal cascade, abnormalities in the other portions
of the afferent, central and efferent neurocardiovascular
reflex arc cannot be excluded. Also, the estimated TPR does
not allow us to differentiate the venous from arterial
contribution. Additional studies are needed to further in-
vestigate the basic mechanisms of vasomotor dysfunction in
patients with vasovagal syncope.
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